This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Bovine Leukemia Virus Antigen
Product Overview
BioVenic's Recombinant Bovine Leukemia Virus Antigen is a recombinant antigen produced by E.coli. This antigen has undergone a rigorous purification process. It can be used for ELISA plate coating or for the preparation of enzyme conjugates.
Specifications
Target Information
Bovine Leukemia Virus (BLV) is an enveloped, single-stranded RNA retrovirus belonging to the genus Deltaretrovirus within the family Retroviridae. It is the causative agent of enzootic bovine leukosis (EBL), a chronic systemic disease affecting cattle worldwide. BLV infects host B-lymphocytes, integrating its proviral DNA into the host genome. While most infections remain subclinical, a subset of animals develops persistent lymphocytosis or malignant lymphosarcomas. The envelope glycoprotein gp51 and capsid protein p24 are major immunodominant antigens routinely targeted in diagnostic serological screenings.
Shipping and Storage
This product is shipped with gel ice bags. Store at 0-4°C for no more than 2 weeks, or -20°C or below for long-term storage.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Aliquote the reconstituted solution to minimise freeze-thaw cycles.